A carregar...

Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System

BACKGROUND: New drugs are needed to treat visceral leishmaniasis (VL) because the current therapies are toxic, expensive, and parasite resistance may weaken drug efficacy. We established a novel ex vivo splenic explant culture system from hamsters infected with luciferase-transfected Leishmania dono...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Osorio, Yaneth, Travi, Bruno L., Renslo, Adam R., Peniche, Alex G., Melby, Peter C.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3039689/
https://ncbi.nlm.nih.gov/pubmed/21358812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000962
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!